27 completed. 27 Phase 1, 11 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 27 | Completed 27 |
| Phase 2 | 11 | Completed 11 |
Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Single Dose Tadalafil on Urethral and Anal Closure Function Tadalafil 40 MG, Placebo - Urinary Incontinence,Stress, Fecal Incontinence | Phase 1 | Completed | University Hospital Bispebjerg and Frederiksberg | 24 | 2021-08-01 | 2022-04-06 |
| Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells Autologous adipose-derived mesenchymal stem cells, Standard treatment according to the Clinical protocols - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 10 | 2020-08-01 | 2021-05-25 |
| Multisystem Cell Therapy for Improvement of Urinary Continence Muscle Precursor Cells (MPCs), ATMP - Urinary Stress Incontinence | Phase 1 | Completed | University of Zurich | 10 | 2020-01-22 | 2021-11-03 |
| Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet - Stress Urinary Incontinence, Fecal Incontinence | Phase 1 | Completed | University Hospital Bispebjerg and Frederiksberg | 24 | 2019-09-17 | 2021-06-09 |
| DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence Litoxetine, placebo - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Ixaltis SA | 84 | 2018-04-03 | 2020-06-11 |
| Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells Autologous adipose-derived mesenchymal stem cells, Standard treatment according to the Clinical protocols - Stress Urinary Incontinence | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 10 | 2018-03-01 | 2020-06-25 |
| Mirabegron For Erectile Dysfunction Mirabegron - Erectile Dysfunction, Overactive Bladder | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2017-08-01 | 2021-01-05 |
| Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? Placebo Oral Tablet, Imipramine Hydrochloride 25 MG - Urinary Incontinence, Stress, Fecal Incontinence | Phase 1 | Completed | Jonatan Kornholt | 16 | 2017-05-16 | 2021-02-12 |
| Autologous Muscle Derived Cells for Underactive Bladder Autologous Muscle Derived Cells - Urinary Retention, Urinary Incontinence | Phase 1 | Completed | Jason Gilleran | 23 | 2016-11-16 | 2022-01-19 |
| A Study of TAS-303 in Female Patients With Stress Urinary Incontinence TAS-303 18mg single-dose, Placebo 18mg single-dose, TAS-303 9mg single-dose - Stress Urinary Incontinence | Phase 1 | Completed | Taiho Pharmaceutical Co., Ltd. | 16 | 2015-10-01 | 2016-08-10 |
| Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery autologous muscle-derived cells (AMDC) - Urinary Incontinence, Stress | Phase 1 / Phase 2 | Completed | Cook MyoSite | 25 | 2015-02-19 | 2021-11-01 |
| Advanced Pelvic Floor Training Program for Prostate Cancer Surgery Advanced Pelvic Floor Muscle Exercise (APFX) - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 1 / Phase 2 | Completed | University of Guelph-Humber | 88 | 2015-01-01 | 2017-10-26 |
| Muscle Progenitor Cell Therapy for Urinary Incontinence Autologous Muscle Progenitor Cells - Urinary Incontinence | Phase 1 | Completed | Wake Forest University | 10 | 2014-01-01 | 2024-03-01 |
| Radiofrequency Non-ablation in the Treatment of Women With Urinary Stress Incontinence: Study Pilot Tonederm® (Radiofrequency non ablative) - Urinary Incontinence | Phase 1 | Completed | Centro de Atenção ao Assoalho Pélvico | 10 | 2013-07-01 | 2015-12-08 |
| Autologous Cell Therapy for Treatment of Fecal Incontinence Iltamiocel - Fecal Incontinence | Phase 1 / Phase 2 | Completed | Cook MyoSite | 53 | 2013-03-28 | 2024-02-16 |
| A Pilot Study to Evaluate Safety and Performance of Neuromuscular Electrical Stimulation With the Inko RS Device for the Treatment of Stress Urinary Incontinence Inko RS Device - Stress Urinary Incontinence | Phase 1 | Completed | Bio-Medical Research, Ltd. | 21 | 2011-12-01 | 2016-02-03 |
| Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Toviaz - Overactive Bladder | Phase 1 | Completed | University of Pennsylvania | 75 | 2011-05-01 | 2014-12-10 |
| Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence UISH001, matching placebo - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Beech Tree Labs, Inc. | 94 | 2011-04-01 | 2013-05-03 |
| A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers YM178 - Healthy Volunteer, Pharmacokinetics of YM178 | Phase 1 | Completed | Astellas Pharma Inc | 12 | 2011-03-01 | 2013-06-12 |
| Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence Transurethral intrasphincteric autologous myoblast implantation - Stress Urinary Incontinence | Phase 1 / Phase 2 | Completed | University Medical Centre Ljubljana | 40 | 2009-08-01 | 2011-05-17 |
Showing 20 of 27. Sign in to see all of them.
Urinary Incontinence, Stress (12) · Urinary Bladder, Overactive (5) · Fecal Incontinence (4) · Lower Urinary Tract Symptoms (3) · Urinary Incontinence, Urge (3) · Encopresis (1) · Erectile Dysfunction (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Prostatic Hyperplasia (1) · Prostatic Neoplasms (1) · Rectal Diseases (1) · Spinal Cord Injuries (1) · Urethral Obstruction (1)
Female Urogenital Diseases (27) · Female Urogenital Diseases and Pregnancy Complications (27) · Male Urogenital Diseases (27) · Pathological Conditions, Signs and Symptoms (27) · Signs and Symptoms (27) · Urogenital Diseases (27) · Urination Disorders (26) · Urologic Diseases (26) · Urological Manifestations (26) · Lower Urinary Tract Symptoms (24) · Urinary Bladder Diseases (6) · Digestive System Diseases (4) · Gastrointestinal Diseases (3) · Genital Diseases (3)
mirabegron (3) · fesoterodine (2) · Citalopram (1) · Fluconazole (1) · Imipramine (1) · Reboxetine (1) · Solifenacin Succinate (1) · TAS-303 (1) · Tadalafil (1) · Tamsulosin (1) · cyclic adenosine-5'-trimetaphosphate (1) · litoxetine (1)
Astellas Pharma Inc (2) · Cook MyoSite (2) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (2) · University Hospital Bispebjerg and Frederiksberg (2) · Assistance Publique - Hôpitaux de Paris (1) · Astellas Pharma Europe B.V. (1) · Beech Tree Labs, Inc. (1) · Bio-Medical Research, Ltd. (1) · Centro de Atenção ao Assoalho Pélvico (1) · Ixaltis SA (1) · Jason Gilleran (1) · Johns Hopkins University (1) · Jonatan Kornholt (1) · Pfizer (1) · Taiho Pharmaceutical Co., Ltd. (1)
United States (11) · Denmark (3) · Belarus (2) · Canada (2) · Japan (2) · France (1) · Germany (1) · Israel (1) · Netherlands (1) · Slovenia (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
Alexander Nechiporenko, Dr (1) · Arthur L Burnett, M.D., M.B.A. (1) · Daniel Eberli, Prof (1) · E Svanberg (1) · Gopal Badlani, MD (1) · Igor D Volotovski, Dr (1) · Igor D Volotovski, Prof (1) · Jacob Bornstein, MD (1) · James Walter, PhD (1) · Janis M Miller, PhD, APRN (1) · Jason Gilleran, MD (1) · Jesper Sonne, DMSc (1) · John OL DeLancey, MD (1)
PMID 22342057, PMID 26377550, PMID 37144409, PMID 38456894, PMID 39076155, PMID 39167201
2009 (1), 2019 (1), P50HD044406 (1)